ACR GUIDELINES Bundle (free trial)

Arteritis ACR 2021

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1449144

Contents of this Issue

Navigation

Page 8 of 13

9 High-dose daily oral GC with TCZ over GC alone; In some instances, can consider GC with MTX or GC alone Consider adding or changing non-GC immunosuppressive agent (e.g., MTX or ABA instead of TCZ) Taper daily oral GC Without any visual symptoms/loss or critical cranial ischemia Clinical remission NO YES ABA, abatacept; GC, glucocorticoids; GCA, Giant cell arteritis; IV, intravenous; MTX, methotrexate; TCZ, tocilizumab

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Arteritis ACR 2021